Puma Biotechnology, Inc.
PBYI
$7.17
$0.091.27%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 24.38M | 31.11M | 36.98M | 48.45M | 38.07M |
| Total Depreciation and Amortization | 9.93M | 10.14M | 9.72M | 9.88M | 10.02M |
| Total Amortization of Deferred Charges | 800.00K | 800.00K | 1.40M | 1.40M | 1.40M |
| Total Other Non-Cash Items | 9.49M | 9.83M | -752.00K | -210.00K | 403.00K |
| Change in Net Operating Assets | 9.00M | -10.08M | -4.36M | -15.18M | -18.61M |
| Cash from Operations | 53.61M | 41.80M | 42.99M | 44.34M | 31.28M |
| Capital Expenditure | -10.00K | -71.00K | -123.00K | -117.00K | -117.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.24M | -36.12M | -11.41M | -11.66M | 290.00K |
| Cash from Investing | -35.25M | -36.19M | -11.53M | -11.78M | 173.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -44.44M | -44.44M | -44.44M | -44.44M | -44.44M |
| Issuance of Common Stock | 130.00K | 130.00K | 130.00K | 280.00K | 150.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -888.00K | -888.00K | -887.00K | -888.00K | -888.00K |
| Cash from Financing | -45.20M | -45.20M | -45.20M | -45.05M | -45.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.84M | -39.58M | -13.74M | -12.49M | -13.72M |